Article Details
Retrieved on: 2021-10-06 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dr. Tebbey's research, development and commercial launch experiences include novel monoclonal antibodies (STELARA® first-in-IL-12/23 class, ...
Article found on: www.kulr8.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here